[1] |
ALEXANDER B M,, CLOUGHESY T F. Adult glioblastoma[J]. J Clin Oncol, 2017, 35(21): 2402-2409.
doi: 10.1200/JCO.2017.73.0119
|
[2] |
LAMOUILLE S,, XU J,, DERYNCK R. Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014, 15(3): 178-196.
doi: 10.1038/nrm3758
|
[3] |
ZANCONATO F,, CORDENONSI M,, PICCOLO S. YAP/TAZ at the roots of cancer[J]. Cancer Cell, 2016, 29(6): 783-803.
doi: 10.1016/j.ccell.2016.05.005
|
[4] |
ZHAO M,, ZHANG Y,, JIANG Y, et al. YAP promotes autophagy and progression of gliomas via upregulating HMGB1[J]. J Exp Clin Cancer Res, 2021, 40(1): 99.
doi: 10.1186/s13046-021-01897-8
|
[5] |
GUICHET P O,, MASLIANTSEV K,, TACHON G, et al. Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence[J]. J Pathol, 2018, 246(2): 205-216.
doi: 10.1002/path.5133
|
[6] |
FU W W,, ZHAO P,, LI H, et al. Bazedoxifene enhances paclitaxel efficacy to suppress glioblastoma via altering Hippo/YAP pathway[J]. J Cancer, 2020, 11(3): 657-667.
doi: 10.7150/jca.38350
|
[7] |
ROTH A F,, WAN J M,, BAILEY A O, et al. Global analysis of protein palmitoylation in yeast[J]. Cell, 2006, 125(5): 1003-1013.
doi: 10.1016/j.cell.2006.03.042
|
[8] |
KO P J,, DIXON S J. Protein palmitoylation and cancer[J]. EMBO Rep, 2018, 19(10): e46666.
|
[9] |
MIZUMARU C,, SAITO Y,, ISHIKAWA T, et al. Suppression of APP-containing vesicle trafficking and production of beta-amyloid by AID/DHHC-12 protein[J]. J Neurochem, 2009, 111(5): 1213-1224.
doi: 10.1111/j.1471-4159.2009.06399.x
|
[10] |
YUAN M,, CHEN X B,, SUN Y T, et al. ZDHHC12-mediated claudin-3 S-palmitoylation determines ovarian cancer progression[J]. Acta Pharm Sin B, 2020, 10(8): 1426-1439.
doi: 10.1016/j.apsb.2020.03.008
|
[11] |
OMURO A,, DEANGELIS L M. Glioblastoma and other malignant gliomas: a clinical review[J]. JAMA, 2013, 310(17): 1842-1850.
doi: 10.1001/jama.2013.280319
|
[12] |
LE RHUN E,, PREUSSER M,, ROTH P, et al. Molecular targeted therapy of glioblastoma[J]. Cancer Treat Rev, 2019, 80: 101896.
doi: 10.1016/j.ctrv.2019.101896
|
[13] |
AIELLO N M,, KANG Y B. Context-dependent EMT programs in cancer metastasis[J]. J Exp Med, 2019, 216(5): 1016-1026.
doi: 10.1084/jem.20181827
|
[14] |
JIANG S Y,, WANG X T,, SONG D L, et al. Cholesterol induces epithelial-to-mesenchymal transition of prostate cancer cells by suppressing degradation of EGFR through APMAP[J]. Cancer Res, 2019, 79(12): 3063-3075.
|
[15] |
FAN L G,, CHEN Z X,, WU X T,, et al. Ubiquitin-specific protease 3 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via stabilizing snail[J]. Mol Cancer Res, 2019, 17(10): 1975-1984.
doi: 10.1158/1541-7786.MCR-19-0197
|
[16] |
PAN D J. The hippo signaling pathway in development and cancer[J]. Dev Cell, 2010, 19(4): 491-505.
doi: 10.1016/j.devcel.2010.09.011
|
[17] |
HONG W J,, GUAN K L. The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway[J]. Semin Cell Dev Biol, 2012, 23(7): 785-793.
doi: 10.1016/j.semcdb.2012.05.004
|
[18] |
SHIBATA M,, HAM K,, HOQUE M O. A time for YAP1: tumorigenesis, immunosuppression and targeted therapy[J]. Int J Cancer, 2018, 143(9): 2133-2144.
doi: 10.1002/ijc.31561
|
[19] |
WANG Y,, PAN P,, WANG Z H, et al. Β-catenin-mediated YAP signaling promotes human glioma growth[J]. J Exp Clin Cancer Res, 2017, 36(1): 136.
doi: 10.1186/s13046-017-0606-1
|
[20] |
ZHANG Y,, XIE P,, WANG X, et al. YAP promotes migration and invasion of human glioma cells[J]. J Mol Neurosci, 2018, 64(2): 262-272.
doi: 10.1007/s12031-017-1018-6
|
[21] |
ARTINIAN N,, CLONINGER C,, HOLMES B, et al. Phosphorylation of the hippo pathway component AMOTL2 by the mTORC2 kinase promotes YAP signaling, resulting in enhanced glioblastoma growth and invasiveness[J]. J Biol Chem, 2015, 290(32): 19387-19401.
doi: 10.1074/jbc.M115.656587
|
[22] |
LEE S,, KANG H,, SHIN E, et al. BEX1 and BEX4 induce GBM progression through regulation of actin polymerization and activation of YAP/TAZ signaling[J]. Int J Mol Sci, 2021, 22(18): 9845.
doi: 10.3390/ijms22189845
|
[23] |
MELHUISH T A,, KOWALCZYK I,, MANUKYAN A, et al. Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression[J]. Biochim Biophys Acta Gene Regul Mech, 2018, 1861(11): 983-995.
doi: 10.1016/j.bbagrm.2018.10.005
|
[24] |
ZHANG Z X,, LI X,, YANG F, et al. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis[J]. Nat Commun, 2021, 12(1): 5872.
doi: 10.1038/s41467-021-26180-4
|
[25] |
CHEN X R,, MA H H,, WANG Z, et al. EZH2 palmitoylation mediated by ZDHHC5 in p53-mutant glioma drives malignant development and progression[J]. Cancer Res, 2017, 77(18): 4998-5010.
|
[26] |
FAN X Q,, YANG H R,, ZHAO C G, et al. Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation[J]. Stem Cell Res Ther, 2021, 12(1): 107.
doi: 10.1186/s13287-021-02175-2
|
[27] |
CHEN X R,, HAO A J,, LI X, et al. Activation of JNK and p38 MAPK mediated by ZDHHC17 drives glioblastoma multiforme development and malignant progression[J]. Theranostics, 2020, 10(3): 998-1015.
doi: 10.7150/thno.40076
|
[28] |
CHEN X R,, HU L,, YANG H R, et al. DHHC protein family targets different subsets of glioma stem cells in specific niches[J]. J Exp Clin Cancer Res, 2019, 38(1): 25.
doi: 10.1186/s13046-019-1033-2
|
[29] |
SHEN Z C,, WU P F,, WANG F, et al. Gephyrin palmitoylation in basolateral amygdala mediates the anxiolytic action of benzodiazepine[J]. Biol Psychiatry, 2019, 85(3): 202-213.
doi: 10.1016/j.biopsych.2018.09.024
|